{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CUE/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T16:00:16.399Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":4061,"canonical_name":"Cue Biopharma, Inc.","cik":"0001645460","uei":null,"lei":null,"duns":null,"ticker":"CUE"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":69},"count":69,"timeline":[{"ts":"2026-10-14","kind":"sec.filing","form_type":"4","title":"4 — Cue Biopharma, Inc. — 2026-10-14","url_slug":"/sec/cik-0001645460/4/0001725092-26-000019","accession_number":"0001725092-26-000019","importance":30},{"ts":"2026-10-14","kind":"sec.filing","form_type":"4","title":"4 — Cue Biopharma, Inc. — 2026-10-14","url_slug":"/sec/cik-0001645460/4/0002138368-26-000009","accession_number":"0002138368-26-000009","importance":30},{"ts":"2026-10-13","kind":"sec.filing","form_type":"144","title":"144 — Cue Biopharma, Inc. — 2026-10-13","url_slug":"/sec/cik-0001645460/144/0001725092-26-000017","accession_number":"0001725092-26-000017","importance":30},{"ts":"2026-10-12","kind":"sec.insider.10000","reporter":"Lin Shao-Lee","title":"Chief Executive Officer","shares":10000,"price_per_share":27.5,"usd_value":275000,"security_title":"Common Stock","importance":15.275},{"ts":"2026-10-12","kind":"sec.insider.1844","reporter":"Ray Sumita","title":"Chief Legal Compliance Officer","shares":1844,"price_per_share":28.05,"usd_value":51724,"security_title":"Common Stock","importance":15.0517242},{"ts":"2026-10-12","kind":"sec.insider.1144","reporter":"Meluzio Michael Vincent","title":"VP, Prin. Accounting Officer","shares":1144,"price_per_share":28.05,"usd_value":32089,"security_title":"Common Stock","importance":15.0320892},{"ts":"2026-10-12","kind":"sec.insider.1087","reporter":"Lin Shao-Lee","title":"Chief Executive Officer","shares":1087,"price_per_share":28.05,"usd_value":30490,"security_title":"Common Stock","importance":15.03049035},{"ts":"2026-10-08","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Cue Biopharma, Inc. — 2026-10-08","url_slug":"/sec/cik-0001645460/schedule-13g-a/0001213900-26-107721","accession_number":"0001213900-26-107721","importance":30},{"ts":"2026-09-21","kind":"sec.filing","form_type":"8-K","title":"8-K — Cue Biopharma, Inc. — 2026-09-21","url_slug":"/sec/cik-0001645460/8-k/0001193125-26-396094","accession_number":"0001193125-26-396094","importance":35},{"ts":"2026-08-28","kind":"sec.filing","form_type":"4/A","title":"4/A — Cue Biopharma, Inc. — 2026-08-28","url_slug":"/sec/cik-0001645460/4-a/0001974756-26-000006","accession_number":"0001974756-26-000006","importance":30},{"ts":"2026-08-28","kind":"sec.filing","form_type":"4/A","title":"4/A — Cue Biopharma, Inc. — 2026-08-28","url_slug":"/sec/cik-0001645460/4-a/0002059447-26-000006","accession_number":"0002059447-26-000006","importance":30},{"ts":"2026-08-21","kind":"sec.filing","form_type":"SCHEDULE 13D","title":"SCHEDULE 13D — Cue Biopharma, Inc. — 2026-08-21","url_slug":"/sec/cik-0001645460/schedule-13d/0001725092-26-000015","accession_number":"0001725092-26-000015","importance":75},{"ts":"2026-08-20","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Cue Biopharma, Inc. — 2026-08-20","url_slug":"/sec/cik-0001645460/effect/9999999995-26-002724","accession_number":"9999999995-26-002724","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"CORRESP","title":"CORRESP — Cue Biopharma, Inc. — 2026-08-18","url_slug":"/sec/cik-0001645460/corresp/0001193125-26-355392","accession_number":"0001193125-26-355392","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"4","title":"4 — Cue Biopharma, Inc. — 2026-08-17","url_slug":"/sec/cik-0001645460/4/0002138368-26-000007","accession_number":"0002138368-26-000007","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"UPLOAD","title":"UPLOAD — Cue Biopharma, Inc. — 2026-08-17","url_slug":"/sec/cik-0001645460/upload/0000000000-26-008092","accession_number":"0000000000-26-008092","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Cue Biopharma, Inc. — 2026-08-14","url_slug":"/sec/cik-0001645460/schedule-13g/0000938206-26-000041","accession_number":"0000938206-26-000041","importance":55},{"ts":"2026-08-14","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Cue Biopharma, Inc. — 2026-08-14","url_slug":"/sec/cik-0001645460/10-q/0001193125-26-352128","accession_number":"0001193125-26-352128","importance":45},{"ts":"2026-08-14","kind":"sec.filing","form_type":"8-K","title":"8-K — Cue Biopharma, Inc. — 2026-08-14","url_slug":"/sec/cik-0001645460/8-k/0001193125-26-352126","accession_number":"0001193125-26-352126","importance":35},{"ts":"2026-08-14","kind":"sec.filing","form_type":"144","title":"144 — Cue Biopharma, Inc. — 2026-08-14","url_slug":"/sec/cik-0001645460/144/0001725092-26-000011","accession_number":"0001725092-26-000011","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"4","title":"4 — Cue Biopharma, Inc. — 2026-08-14","url_slug":"/sec/cik-0001645460/4/0001725092-26-000013","accession_number":"0001725092-26-000013","importance":30},{"ts":"2026-08-13","kind":"sec.insider.s","reporter":"Lin Shao-Lee","title":"Chief Executive Officer","shares":10460,"price_per_share":29.48,"usd_value":308361,"security_title":"Common Stock","importance":35.3083608},{"ts":"2026-08-13","kind":"sec.insider.s","reporter":"Lin Shao-Lee","title":"Chief Executive Officer","shares":5423,"price_per_share":27.19,"usd_value":147451,"security_title":"Common Stock","importance":35.14745137},{"ts":"2026-08-13","kind":"sec.insider.s","reporter":"Lin Shao-Lee","title":"Chief Executive Officer","shares":2375,"price_per_share":28.11,"usd_value":66761,"security_title":"Common Stock","importance":35.06676125},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Lin Shao-Lee","title":"Chief Executive Officer","shares":34225,"price_per_share":26.99,"usd_value":923733,"security_title":"Common Stock","importance":35.92373275},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Lin Shao-Lee","title":"Chief Executive Officer","shares":5775,"price_per_share":27.75,"usd_value":160256,"security_title":"Common Stock","importance":35.16025625},{"ts":"2026-08-12","kind":"sec.filing","form_type":"S-3","title":"S-3 — Cue Biopharma, Inc. — 2026-08-12","url_slug":"/sec/cik-0001645460/s-3/0001193125-26-346867","accession_number":"0001193125-26-346867","importance":30},{"ts":"2026-08-12","kind":"sec.insider.m","reporter":"Lin Shao-Lee","title":"Chief Executive Officer","shares":109179,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-08-03","kind":"sec.filing","form_type":"8-K","title":"8-K — Cue Biopharma, Inc. — 2026-08-03","url_slug":"/sec/cik-0001645460/8-k/0001193125-26-330730","accession_number":"0001193125-26-330730","importance":35},{"ts":"2026-07-30","kind":"sec.filing","form_type":"4/A","title":"4/A — Cue Biopharma, Inc. — 2026-07-30","url_slug":"/sec/cik-0001645460/4-a/0001725092-26-000009","accession_number":"0001725092-26-000009","importance":30},{"ts":"2026-07-30","kind":"sec.insider.a","reporter":"Ahlers James M","title":"Chief Financial Officer","shares":25500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-22","kind":"sec.filing","form_type":"D","title":"D — Cue Biopharma, Inc. — 2026-07-22","url_slug":"/sec/cik-0001645460/d/0001645460-26-000004","accession_number":"0001645460-26-000004","importance":30},{"ts":"2026-07-15","kind":"sec.filing","form_type":"3","title":"3 — Cue Biopharma, Inc. — 2026-07-15","url_slug":"/sec/cik-0001645460/3/0002008790-26-000004","accession_number":"0002008790-26-000004","importance":30},{"ts":"2026-07-15","kind":"sec.filing","form_type":"4","title":"4 — Cue Biopharma, Inc. — 2026-07-15","url_slug":"/sec/cik-0001645460/4/0002008790-26-000006","accession_number":"0002008790-26-000006","importance":30},{"ts":"2026-07-13","kind":"sec.insider.a","reporter":"Borie Dominique Christian","title":"Chief Medical Officer","shares":31500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-10","kind":"sec.filing","form_type":"8-K","title":"8-K — Cue Biopharma, Inc. — 2026-07-10","url_slug":"/sec/cik-0001645460/8-k/0001193125-26-301052","accession_number":"0001193125-26-301052","importance":35},{"ts":"2026-07-10","kind":"sec.filing","form_type":"4","title":"4 — Cue Biopharma, Inc. — 2026-07-10","url_slug":"/sec/cik-0001645460/4/0001725092-26-000006","accession_number":"0001725092-26-000006","importance":30},{"ts":"2026-07-10","kind":"sec.filing","form_type":"4","title":"4 — Cue Biopharma, Inc. — 2026-07-10","url_slug":"/sec/cik-0001645460/4/0001820365-26-000009","accession_number":"0001820365-26-000009","importance":30},{"ts":"2026-07-10","kind":"sec.filing","form_type":"4","title":"4 — Cue Biopharma, Inc. — 2026-07-10","url_slug":"/sec/cik-0001645460/4/0001974756-26-000004","accession_number":"0001974756-26-000004","importance":30},{"ts":"2026-07-10","kind":"sec.filing","form_type":"4","title":"4 — Cue Biopharma, Inc. — 2026-07-10","url_slug":"/sec/cik-0001645460/4/0002059447-26-000004","accession_number":"0002059447-26-000004","importance":30},{"ts":"2026-07-10","kind":"sec.filing","form_type":"4","title":"4 — Cue Biopharma, Inc. — 2026-07-10","url_slug":"/sec/cik-0001645460/4/0002137444-26-000007","accession_number":"0002137444-26-000007","importance":30},{"ts":"2026-07-10","kind":"sec.filing","form_type":"4","title":"4 — Cue Biopharma, Inc. — 2026-07-10","url_slug":"/sec/cik-0001645460/4/0002138368-26-000005","accession_number":"0002138368-26-000005","importance":30},{"ts":"2026-07-09","kind":"sec.insider.21800","reporter":"Garzone Pamela","title":null,"shares":21800,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-09","kind":"sec.insider.a","reporter":"Ray Sumita","title":"Chief Legal Compliance Officer","shares":54589,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-09","kind":"sec.insider.a","reporter":"Lin Shao-Lee","title":"Chief Executive Officer","shares":327537,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-09","kind":"sec.insider.a","reporter":"Camardo Daniel A.","title":"","shares":21800,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-09","kind":"sec.insider.a","reporter":"Garzone Pamela","title":"","shares":21800,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-09","kind":"sec.insider.a","reporter":"Meehan Viola Mong","title":"","shares":21800,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-09","kind":"sec.insider.a","reporter":"Sarraf Pasha","title":"","shares":21800,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-09","kind":"sec.insider.a","reporter":"Meluzio Michael Vincent","title":"VP, Prin. Accounting Officer","shares":40942,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Cue Biopharma, Inc. — 2026-07-01","url_slug":"/sec/cik-0001645460/effect/9999999995-26-002180","accession_number":"9999999995-26-002180","importance":30},{"ts":"2026-06-29","kind":"sec.filing","form_type":"CORRESP","title":"CORRESP — Cue Biopharma, Inc. — 2026-06-29","url_slug":"/sec/cik-0001645460/corresp/0001193125-26-288417","accession_number":"0001193125-26-288417","importance":30},{"ts":"2026-06-25","kind":"sec.filing","form_type":"UPLOAD","title":"UPLOAD — Cue Biopharma, Inc. — 2026-06-25","url_slug":"/sec/cik-0001645460/upload/0000000000-26-006372","accession_number":"0000000000-26-006372","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"S-3","title":"S-3 — Cue Biopharma, Inc. — 2026-06-18","url_slug":"/sec/cik-0001645460/s-3/0001193125-26-275808","accession_number":"0001193125-26-275808","importance":30},{"ts":"2026-06-17","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Cue Biopharma, Inc. — 2026-06-17","url_slug":"/sec/cik-0001645460/effect/9999999995-26-002046","accession_number":"9999999995-26-002046","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"CORRESP","title":"CORRESP — Cue Biopharma, Inc. — 2026-06-15","url_slug":"/sec/cik-0001645460/corresp/0001193125-26-271175","accession_number":"0001193125-26-271175","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"3","title":"3 — Cue Biopharma, Inc. — 2026-06-11","url_slug":"/sec/cik-0001645460/3/0002138368-26-000003","accession_number":"0002138368-26-000003","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"UPLOAD","title":"UPLOAD — Cue Biopharma, Inc. — 2026-06-10","url_slug":"/sec/cik-0001645460/upload/0000000000-26-005827","accession_number":"0000000000-26-005827","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"3","title":"3 — Cue Biopharma, Inc. — 2026-06-08","url_slug":"/sec/cik-0001645460/3/0001820365-26-000004","accession_number":"0001820365-26-000004","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"4","title":"4 — Cue Biopharma, Inc. — 2026-06-08","url_slug":"/sec/cik-0001645460/4/0001820365-26-000006","accession_number":"0001820365-26-000006","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"8-K","title":"8-K — Cue Biopharma, Inc. — 2026-06-03","url_slug":"/sec/cik-0001645460/8-k/0001193125-26-255479","accession_number":"0001193125-26-255479","importance":35},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — Cue Biopharma, Inc. — 2026-06-03","url_slug":"/sec/cik-0001645460/4/0001725092-26-000004","accession_number":"0001725092-26-000004","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"S-3","title":"S-3 — Cue Biopharma, Inc. — 2026-06-03","url_slug":"/sec/cik-0001645460/s-3/0001193125-26-255418","accession_number":"0001193125-26-255418","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"S-8","title":"S-8 — Cue Biopharma, Inc. — 2026-06-03","url_slug":"/sec/cik-0001645460/s-8/0001193125-26-255427","accession_number":"0001193125-26-255427","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — Cue Biopharma, Inc. — 2026-05-21","url_slug":"/sec/cik-0001645460/def-14a/0001193125-26-233369","accession_number":"0001193125-26-233369","importance":40},{"ts":"2026-05-14","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Cue Biopharma, Inc. — 2026-05-14","url_slug":"/sec/cik-0001645460/10-q/0001193125-26-224091","accession_number":"0001193125-26-224091","importance":45},{"ts":"2026-05-14","kind":"sec.filing","form_type":"8-K","title":"8-K — Cue Biopharma, Inc. — 2026-05-14","url_slug":"/sec/cik-0001645460/8-k/0001193125-26-224101","accession_number":"0001193125-26-224101","importance":35},{"ts":"2026-05-14","kind":"sec.filing","form_type":"D","title":"D — Cue Biopharma, Inc. — 2026-05-14","url_slug":"/sec/cik-0001645460/d/0001645460-26-000003","accession_number":"0001645460-26-000003","importance":30},{"ts":"2026-05-11","kind":"sec.filing","form_type":"PRE 14A","title":"PRE 14A — Cue Biopharma, Inc. — 2026-05-11","url_slug":"/sec/cik-0001645460/pre-14a/0001193125-26-217130","accession_number":"0001193125-26-217130","importance":30}]}